newsfilter
← Latest News
GlobeNewswire·

Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence Biomed" or the "Company") today announced that it has received notice from the Nasdaq Hearings panel that the Company has